Fc receptors are major mediators of antibody based inflammation in autoimmunity - PubMed (original) (raw)
Review
Fc receptors are major mediators of antibody based inflammation in autoimmunity
P Mark Hogarth. Curr Opin Immunol. 2002 Dec.
Abstract
There is now renewed interest in the role of antibodies in autoimmunity. Recent compelling evidence indicates that autoantibodies and the effector mechanisms they induce, for example, Fc receptor activation of leukocytes and/or the complement cascade, are central players in the development of autoimmunity, by perpetuating inflammation and perhaps even regulating the process itself. Of increasing interest are Fc receptors, which have been more closely investigated in the past decade using recombinant proteins, gene deficient mice and mouse models of human disease. These analyses point towards major roles of Fc receptors in antibody hypersensitivity reactions and by extension autoimmune disease, and they reveal opportunities in the development of novel therapeutic approaches in the treatment of autoimmune diseases.
Similar articles
- Fc receptors and their interaction with complement in autoimmunity.
Schmidt RE, Gessner JE. Schmidt RE, et al. Immunol Lett. 2005 Aug 15;100(1):56-67. doi: 10.1016/j.imlet.2005.06.022. Immunol Lett. 2005. PMID: 16125792 Review. - The impact of Fc receptors on the development of autoimmune diseases.
Kleinau S. Kleinau S. Curr Pharm Des. 2003;9(23):1861-70. doi: 10.2174/1381612033454414. Curr Pharm Des. 2003. PMID: 12871190 Review. - Inflammation in autoimmunity: receptors for IgG revisited.
Dijstelbloem HM, van de Winkel JG, Kallenberg CG. Dijstelbloem HM, et al. Trends Immunol. 2001 Sep;22(9):510-6. doi: 10.1016/s1471-4906(01)02014-2. Trends Immunol. 2001. PMID: 11525942 Review. - IgG Fc receptors.
Ravetch JV, Bolland S. Ravetch JV, et al. Annu Rev Immunol. 2001;19:275-90. doi: 10.1146/annurev.immunol.19.1.275. Annu Rev Immunol. 2001. PMID: 11244038 Review. - The IgG Fc receptor family.
Gessner JE, Heiken H, Tamm A, Schmidt RE. Gessner JE, et al. Ann Hematol. 1998 Jun;76(6):231-48. doi: 10.1007/s002770050396. Ann Hematol. 1998. PMID: 9692811 Review.
Cited by
- Novel Human FCGR1A Variants Affect CD64 Functions and Are Risk Factors for Sarcoidosis.
Wu J, Li Y, Rendahl A, Bhargava M. Wu J, et al. Front Immunol. 2022 Mar 17;13:841099. doi: 10.3389/fimmu.2022.841099. eCollection 2022. Front Immunol. 2022. PMID: 35371020 Free PMC article. - FcγR Genetic Variation and HIV-1 Vaccine Efficacy: Context And Considerations.
Lassaunière R, Tiemessen CT. Lassaunière R, et al. Front Immunol. 2021 Dec 15;12:788203. doi: 10.3389/fimmu.2021.788203. eCollection 2021. Front Immunol. 2021. PMID: 34975881 Free PMC article. - Anti-Leishmania infantum Antibody-Producing Plasma Cells in the Spleen in Canine Visceral Leishmaniasis.
Fontes JLM, Mesquita BR, Brito R, Gomes JCS, de Melo CVB, Dos Santos WLC. Fontes JLM, et al. Pathogens. 2021 Dec 17;10(12):1635. doi: 10.3390/pathogens10121635. Pathogens. 2021. PMID: 34959592 Free PMC article. - Glycosylation of Antigen-Specific Antibodies: Perspectives on Immunoglobulin G Glycosylation in Vaccination and Immunotherapy.
Bharadwaj P, Ackerman ME. Bharadwaj P, et al. Exp Suppl. 2021;112:565-587. doi: 10.1007/978-3-030-76912-3_18. Exp Suppl. 2021. PMID: 34687023 - Accelerated Clearance and Degradation of Cell-Free HIV by Neutralizing Antibodies Occurs via FcγRIIb on Liver Sinusoidal Endothelial Cells by Endocytosis.
Turman JM, Cheplowitz AM, Tiwari C, Thomas T, Joshi D, Bhat M, Wu Q, Pong E, Chu SY, Szymkowski DE, Sharma A, Seveau S, Robinson JM, Kwiek JJ, Burton D, Rajaram MVS, Kim J, Hangartner L, Ganesan LP. Turman JM, et al. J Immunol. 2021 Mar 15;206(6):1284-1296. doi: 10.4049/jimmunol.2000772. Epub 2021 Feb 10. J Immunol. 2021. PMID: 33568400 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous